Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Multi-center Noninterventional Study to Evaluate the Effectiveness of Neupro® (Rotigotine Transdermal Patch) and Levodopa Combination Therapy in Patients With Parkinson's Disease (NEUPART)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02227355
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:11.252733+00:00
Published At
2016-07-04T00:00:00+00:00
Record Updated At
2016-07-04
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Idiopathic Parkinson\u0027s Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-07-04"
protocolSection.identificationModule.nctId
"NCT02227355"
protocolSection.identificationModule.officialTitle
"A Multi-center Noninterventional Study to Evaluate the Effectiveness of Neupro\u00ae (Rotigotine Transdermal Patch) and Levodopa Combination Therapy in Patients With Parkinson\u0027s Disease (NEUPART)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Idiopathic Parkinson's Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.